MCID: HMP009
MIFTS: 44

Haemophilus Influenzae

Categories: Rare diseases, Infectious diseases

Aliases & Classifications for Haemophilus Influenzae

Summaries for Haemophilus Influenzae

MalaCards based summary : Haemophilus Influenzae, also known as h. influenzae, is related to neonatal meningitis and aseptic meningitis. An important gene associated with Haemophilus Influenzae is OMP (Olfactory Marker Protein), and among its related pathways/superpathways are Innate Immune System and Influenza A. The drugs Amoxicillin and Estradiol have been mentioned in the context of this disorder. Affiliated tissues include lung, colon and testes, and related phenotypes are hematopoietic system and homeostasis/metabolism

Wikipedia : 72 Haemophilus influenzae (formerly called Pfeiffer\'s bacillus or Bacillus influenzae) is a Gram-negative,... more...

Related Diseases for Haemophilus Influenzae

Diseases related to Haemophilus Influenzae via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 236)
id Related Disease Score Top Affiliating Genes
1 neonatal meningitis 30.4 OMP TLR2
2 aseptic meningitis 30.0 TLR2 TNF
3 pyelonephritis 29.6 CXCL8 ICAM1 TNF
4 haemophilus meningitis 11.6
5 epiglottitis 11.4
6 influenza 11.0
7 c3 deficiency 11.0
8 specific antibody deficiency 11.0
9 bronchitis 10.7
10 mycobacterium malmoense 10.6 CXCL8 TLR2
11 mycobacterium xenopi 10.6 CXCL8 TLR2
12 tetanus 10.6
13 basidiobolomycosis 10.6 CXCL8 TNF
14 spirillary rat-bite fever 10.6 CXCL8 TNF
15 tarsal tunnel syndrome 10.5 CXCL8 TNF
16 plantar wart 10.5 CXCL8 TNF
17 pertussis 10.5
18 amyotrophic lateral sclerosis type 10 10.5 CXCL8 TNF
19 diphtheria 10.5
20 granuloma inguinale 10.5 CXCL8 TLR2
21 pasteurellosis 10.5 CXCL8 TNF
22 epulis 10.5 CXCL8 TNF
23 congenital diaphragmatic hernia 10.5 CXCL8 ICAM1
24 trachea sarcoma 10.5 CXCL8 TNF
25 cytomegalovirus retinitis 10.5 CXCL8 ICAM1
26 cicatricial lagophthalmos 10.5 CXCL8 TNF
27 congenital insensitivity to pain with hyperhidrosis 10.5 CXCL8 LTF
28 euthyroid sick syndrome 10.5 TF TNF
29 lymphangiectasia, intestinal 10.5 CXCL8 LTF
30 retinal vascular disease 10.5 CXCL8 LTF
31 meningitis 10.5
32 rickettsialpox 10.5 TLR2 TNF
33 tricho onychic dysplasia 10.5 CXCL8 TNF
34 superior vena cava syndrome 10.5 LTF TF
35 pneumonia 10.4
36 pituicytoma 10.4 LTF TF
37 trichosporonosis 10.4 TLR2 TNF
38 thymus clear cell carcinoma 10.4 CXCL8 TLR2
39 not otherwise specified 3-mga-uria type 10.4 TLR2 TNF
40 steatorrhea 10.4 CXCL8 TNF
41 acquired thrombocytopenia 10.4 CXCL8 TNF
42 hepatitis 10.4
43 early-onset zonular cataract 10.4 TF TNF
44 hepatitis b 10.4
45 total internal ophthalmoplegia 10.4 CLEC7A CXCL8
46 otitis media 10.4
47 lip cancer 10.3 CXCL8 TNF
48 moved to 244450 10.3 ICAM1 TNF
49 uveitis 10.3 ICAM1 TNF
50 chromoblastomycosis 10.3 ICAM1 TNF

Graphical network of the top 20 diseases related to Haemophilus Influenzae:



Diseases related to Haemophilus Influenzae

Symptoms & Phenotypes for Haemophilus Influenzae

MGI Mouse Phenotypes related to Haemophilus Influenzae:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.56 CFH CLEC7A ICAM1 LTF TF TLR2
2 homeostasis/metabolism MP:0005376 9.28 TLR2 TNF VTN CFH CLEC7A ICAM1

Drugs & Therapeutics for Haemophilus Influenzae

Drugs for Haemophilus Influenzae (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 132)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 26787-78-0 33613 2171
2
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
3
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
4
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
5
Norgestimate Approved Phase 4 35189-28-7 6540478
6
Edetic Acid Approved, Vet_approved Phase 4,Phase 3,Phase 2 60-00-4, 62-33-9 6049
7
Iron Approved Phase 4,Phase 3,Phase 2 7439-89-6 23925
8
Acetaminophen Approved Phase 4,Phase 3 103-90-2 1983
9
Ibuprofen Approved Phase 4 15687-27-1 3672
10
Azithromycin Approved Phase 4 83905-01-5 55185 53477736 447043
11 Strawberry Approved, Nutraceutical Phase 4,Phase 3
12 Amoxicillin-Potassium Clavulanate Combination Phase 4,Phase 3,Phase 2
13 Anti-Bacterial Agents Phase 4,Phase 3,Phase 1,Phase 2
14 Anti-Infective Agents Phase 4,Phase 3,Phase 1,Phase 2
15 beta-Lactamase Inhibitors Phase 4,Phase 3,Phase 2
16 Clavulanic Acid Phase 4,Phase 3,Phase 2
17 Vaccines Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
18 Antibodies Phase 4,Phase 3,Phase 2,Phase 1
19 Immunoglobulins Phase 4,Phase 3,Phase 2,Phase 1
20 Heptavalent Pneumococcal Conjugate Vaccine Phase 4,Phase 3,Phase 2,Phase 1
21 Fluoroquinolones Phase 4,Phase 3
22 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3
23 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
24 MF59 oil emulsion Phase 4
25 Contraceptive Agents Phase 4
26 Contraceptives, Oral Phase 4
27 Contraceptives, Oral, Combined Phase 4
28 Estradiol 17 beta-cypionate Phase 4
29 Estradiol 3-benzoate Phase 4
30 Estradiol valerate Phase 4 979-32-8
31 Norgestimate, ethinyl estradiol drug combination Phase 4
32 Polyestradiol phosphate Phase 4
33 Ophthalmic Solutions Phase 4
34 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1
35 Anticoagulants Phase 4,Phase 3,Phase 2
36 Antidotes Phase 4,Phase 3,Phase 2
37 Calcium, Dietary Phase 4,Phase 3,Phase 2
38 Chelating Agents Phase 4,Phase 3,Phase 2
39 Iron Chelating Agents Phase 4,Phase 3,Phase 2
40 Pentetic Acid Phase 4,Phase 3,Phase 2
41 Protective Agents Phase 4,Phase 3,Phase 2
42 Analgesics Phase 4,Phase 3,Phase 1
43 Analgesics, Non-Narcotic Phase 4,Phase 3
44 Anti-Inflammatory Agents Phase 4
45 Anti-Inflammatory Agents, Non-Steroidal Phase 4
46 Antipyretics Phase 4,Phase 3
47 Antirheumatic Agents Phase 4
48 Cyclooxygenase Inhibitors Phase 4
49 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 1
50 Antitoxins Phase 4,Phase 3

Interventional clinical trials:

(show top 50) (show all 288)

id Name Status NCT ID Phase Drugs
1 Middle Meatal Bacteriology During Acute Respiratory Infection in Children Unknown status NCT00545961 Phase 4 placebo;amoxicillin clavulanate acid
2 Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine Unknown status NCT00877357 Phase 4
3 Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children Completed NCT01404962 Phase 4
4 The Safety and Immunogenicity of Haemophilus Influenzae Type b Vaccine in Different Injection Site Completed NCT01761136 Phase 4
5 Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw Vaccine Completed NCT00158795 Phase 4
6 Study to Eliminate Hib Carriage in Rural Alaska Native Villages Completed NCT00153556 Phase 4
7 The Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib Vaccine Completed NCT00197782 Phase 4
8 Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine Completed NCT00454987 Phase 4
9 Hepatitis B Vaccination in Infants Completed NCT01896596 Phase 4
10 Immunogenicity of the Booster Dose of Two MenC Vaccines Completed NCT00392808 Phase 4
11 Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years Completed NCT02215863 Phase 4
12 Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox Completed NCT00668304 Phase 4 Avelox (Moxifloxacin, BAY12-8039)
13 Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora Completed NCT00312338 Phase 4 VIGAMOX
14 Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine Completed NCT00674908 Phase 4
15 Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine Completed NCT00617812 Phase 4
16 Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068) Completed NCT00289913 Phase 4
17 Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants Completed NCT00325156 Phase 4
18 Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines Completed NCT00254917 Phase 4
19 Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ Completed NCT01358825 Phase 4
20 Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants Completed NCT00753649 Phase 4
21 Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course Completed NCT01457547 Phase 4
22 Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age Completed NCT01659996 Phase 4
23 Retrospective Survey of Safety of Fourth Dose Pentacel® in Children Completed NCT00772369 Phase 4
24 Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand Completed NCT00255021 Phase 4
25 Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™ Completed NCT00802867 Phase 4
26 Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China Completed NCT01491087 Phase 4
27 Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13® Completed NCT01392378 Phase 4 Paracetamol;Ibuprofen;Paracetamol;Ibuprofen
28 Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination Completed NCT01357720 Phase 4
29 Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency Completed NCT00520494 Phase 4 Vivaglobin
30 Tripartite International Research for the Elimination of Trachoma Completed NCT01202331 Phase 4 mass treatment with oral azithromycin
31 Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery Recruiting NCT02422264 Phase 4 Prevnar13
32 Vaccinating Children After Chemotherapy Recruiting NCT02447718 Phase 4
33 Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery Recruiting NCT02853929 Phase 4
34 Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B Active, not recruiting NCT03125616 Phase 4
35 Study Comparing DTP-HB-Hib by Disposable-Syringe Jet Injector To Vaccination By Needle And Syringe In Infants Terminated NCT02409095 Phase 4
36 Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine,Freeze-dried Unknown status NCT02560272 Phase 3
37 Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children Unknown status NCT01619462 Phase 3
38 Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection Unknown status NCT02368470 Phase 3 Gemifloxacin-based triple therapy;Standard triple therapy
39 Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b Completed NCT00808392 Phase 3
40 Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in China Completed NCT01025544 Phase 3
41 Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in China Completed NCT01044316 Phase 3
42 A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine Completed NCT02692859 Phase 3
43 Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy Infants Completed NCT01226953 Phase 3
44 Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese Children Completed NCT02139228 Phase 3
45 Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED) Completed NCT00441012 Phase 3
46 Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children Completed NCT01125527 Phase 3
47 Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age Completed NCT01019772 Phase 3
48 Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B Completed NCT01362517 Phase 3
49 Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age Completed NCT00345579 Phase 3
50 Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) Completed NCT00092469 Phase 3

Search NIH Clinical Center for Haemophilus Influenzae

Genetic Tests for Haemophilus Influenzae

Anatomical Context for Haemophilus Influenzae

MalaCards organs/tissues related to Haemophilus Influenzae:

39
Lung, Colon, Testes, B Cells, Tonsil, Monocytes, Neutrophil

Publications for Haemophilus Influenzae

Articles related to Haemophilus Influenzae:

(show top 50) (show all 589)
id Title Authors Year
1
Bacteremic renal stone-associated urinary tract infection caused by nontypable Haemophilus influenzae: A rare invasive disease in an immunocompetent patient. ( 27920983 )
2017
2
Nontypeable Haemophilus influenzae (NTHi) directly interfere with the regulation of E-cadherin in lung epithelial cells. ( 28802586 )
2017
3
Haemophilus influenzae biofilms in primary ciliary dyskinesia: a moving story. ( 28890441 )
2017
4
Haemophilus influenzae Type b Invasive Disease in Amish Children, Missouri, USA, 2014. ( 27983486 )
2017
5
Blood-Brain Barrier in a Haemophilus influenzae Type a In Vitro Infection: Role of Adenosine Receptors A2A and A2B. ( 28921456 )
2017
6
Beta-lactam resistance among Haemophilus influenzae isolates in Poland. ( 28818575 )
2017
7
Immunogenicity of Nontypeable Haemophilus influenzae Outer Membrane Vesicles and Protective Ability in the Chinchilla Model of Otitis Media. ( 28768669 )
2017
8
Antimicrobial susceptibility of Haemophilus influenzae strains isolated from the urethra of men with acute urethritis and/or epididymitis. ( 28619239 )
2017
9
Haemophilus influenzae Serotype f Epiglottitis: A Case Report and Review. ( 28028010 )
2017
10
Immunogenicity, safety and reactogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in 2-17-year-old children with asplenia or splenic dysfunction: A phase 3 study. ( 28866290 )
2017
11
The carriage of interleukin-1B-31*C allele plus Staphylococcus aureus and Haemophilus influenzae increases the risk of recurrent tonsillitis in a Mexican population. ( 28542534 )
2017
12
Paediatric invasive Haemophilus influenzae in Queensland, Australia, 2002-2011: Young Indigenous children remain at highest risk. ( 28871608 )
2017
13
Amino acid substitution in the major multi-drug efflux transporter protein AcrB contributes to azithromycin low-susceptibility in Haemophilus influenzae. ( 28848006 )
2017
14
Experimental design and metabolic flux analysis tools to optimize industrially relevant Haemophilus influenzae type b growth medium. ( 28840658 )
2017
15
Investigating the candidacy of a capsular polysaccharide-based glycoconjugate as a vaccine to combat Haemophilus influenzae type a disease: A solution for an unmet public health need. ( 28951087 )
2017
16
Vaccine Candidates against Nontypeable Haemophilus influenzae: a Review ( 28088130 )
2017
17
Haemophilus influenzae Pyomyositis in a Patient with Diabetic Ketoacidosis: A Unique Case and Review of Literature. ( 28352482 )
2017
18
Haemophilus influenzae vulvovaginitis associated with rhinitis caused by the same clone in a prepubertal girl. ( 28621044 )
2017
19
Pneumonia prevention: Cost-effectiveness analyses of two vaccines among refugee children aged under two years, Haemophilus influenzae type b-containing and pneumococcal conjugate vaccines, during a humanitarian emergency, Yida camp, South Sudan. ( 27989625 )
2017
20
Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b. ( 28903749 )
2017
21
Antimicrobial activity of antisense peptide-peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms. ( 27986898 )
2017
22
Fulminant Haemophilus influenzae Type A Infection in a 4-year-Old with Previously Undiagnosed Asplenic Heterotaxy. ( 28858039 )
2017
23
Epidemiology of invasive pneumococcal and haemophilus influenzae diseases in northwestern ontario, canada (2010-2015). ( 28951105 )
2017
24
Haemophilus influenzae Isolated From Men With Acute Urethritis: Its Pathogenic Roles, Responses to Antimicrobial Chemotherapies, and Antimicrobial Susceptibilities. ( 28282645 )
2017
25
Structural analyses of the Haemophilus influenzae peptidoglycan synthase activator LpoA suggest multiple conformations in solution. ( 28887305 )
2017
26
Primary ciliary dyskinesia ciliated airwayA cells show increased susceptibility to Haemophilus influenzae biofilm formation. ( 28890436 )
2017
27
Cephalosporin-3'-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms. ( 27919896 )
2017
28
Response to Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland. ( 28064237 )
2017
29
Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran. ( 28088246 )
2017
30
Development of a highly resolved loop-mediated isothermal amplification method to detect the N526K ftsI mutation of I^-lactamase-negative ampicillin-resistant Haemophilus influenzae. ( 28807759 )
2017
31
Conservation and Recombination in the Genome Sequence of Haemophilus influenzae Type f WAPHL1. ( 28935730 )
2017
32
Haemophilus influenzae serotype f endocarditis and septic arthritis. ( 28725560 )
2017
33
Resistance of non-typeable Haemophilus influenzae biofilms is independent of biofilm size. ( 27956464 )
2017
34
Alloiococcus otitidis Forms Multispecies Biofilm with Haemophilus influenzae: Effects on Antibiotic Susceptibility and Growth in Adverse Conditions. ( 28824879 )
2017
35
Changes in the prevalence and biofilm formation of Haemophilus influenzae and Haemophilus parainfluenzae from the respiratory microbiota of patients with sarcoidosis. ( 27562460 )
2016
36
Microbiological Characterization of Haemophilus influenzae Isolated from Patients with Lower Respiratory Tract Infections in a Tertiary Care Hospital, South India. ( 27437218 )
2016
37
An Atypical I+/I^-Hydrolase Fold Revealed in the Crystal Structure of Pimeloyl-Acyl Carrier Protein Methyl Esterase BioG from Haemophilus influenzae. ( 27933801 )
2016
38
Antimicrobial resistance in cystic fibrosis isolates of Haemophilus influenzae. ( 27181174 )
2016
39
N-Acetyl-L-cysteine and Cysteamine: New Strategies Against Mixed Biofilms of Non-encapsulated Streptococcus pneumoniae and Non-typeable Haemophilus influenzae. ( 27919900 )
2016
40
Structural basis for haem piracy from host haemopexin by Haemophilus influenzae. ( 27188378 )
2016
41
Oldenlandia diffusa Extract Inhibits Biofilm Formation by Haemophilus influenzae Clinical Isolates. ( 27902758 )
2016
42
Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland. ( 27125273 )
2016
43
A high throughput serum bactericidal assay for antibodies to Haemophilus influenzae type b. ( 27595992 )
2016
44
Antibodies from multiple sclerosis patients preferentially recognize hyperglucosylated adhesin of non-typeable Haemophilus influenzae. ( 28008952 )
2016
45
Non-typeable Haemophilus influenzae protects human airway epithelial cells from a subsequent respiratory syncytial virus challenge. ( 27573069 )
2016
46
Increased Nasopharyngeal Density and Concurrent Carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Are Associated with Pneumonia in Febrile Children. ( 27907156 )
2016
47
Streptococcus pneumoniae and Haemophilus influenzae type b carriage in Chinese children aged 12-18 months in Shanghai, China: a cross-sectional study. ( 27080523 )
2016
48
Prevalence and antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis isolated from patients in Bangkok, Thailand. ( 27436474 )
2016
49
Host-pathogen interactions of nontypeable Haemophilus influenzae: from commensal to pathogen. ( 27508518 )
2016
50
Immunogenicity and Safety Of 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children with Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study. ( 28030521 )
2016

Variations for Haemophilus Influenzae

Expression for Haemophilus Influenzae

Search GEO for disease gene expression data for Haemophilus Influenzae.

Pathways for Haemophilus Influenzae

Pathways related to Haemophilus Influenzae according to GeneCards Suite gene sharing:

(show all 25)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.73 CFH CLEC7A CXCL8 ICAM1 LTF TLR2
2
Show member pathways
12.56 CXCL8 ICAM1 TLR2 TNF
3
Show member pathways
12.13 CXCL8 TLR2 TNF
4 12.09 TLR2 TNF VTN
5 12.03 CLEC7A TLR2 TNF
6
Show member pathways
11.98 CXCL8 TLR2 TNF
7 11.96 CXCL8 TF TNF
8 11.78 CXCL8 ICAM1 TNF
9 11.74 CXCL8 ICAM1 TNF
10 11.67 CXCL8 ICAM1 TNF
11 11.64 CXCL8 TLR2 TNF
12 11.61 CXCL8 ICAM1 TNF
13 11.54 CLEC7A TLR2 VTN
14 11.43 ICAM1 TLR2 TNF
15
Show member pathways
11.34 CXCL8 ICAM1 TNF
16 11.24 CXCL8 TLR2 TNF
17 11.21 CXCL8 ICAM1 TLR2 TNF
18 11.17 ICAM1 TNF
19 11.12 CXCL8 ICAM1 TNF
20 11.01 ICAM1 TNF VTN
21 11 ICAM1 TLR2
22 10.97 CXCL8 TNF
23 10.84 CXCL8 TNF
24 10.75 ICAM1 TNF
25 10.61 CXCL8 ICAM1 TLR2 TNF

GO Terms for Haemophilus Influenzae

Cellular components related to Haemophilus Influenzae according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 membrane raft GO:0045121 9.43 ICAM1 TLR2 TNF
2 cell surface GO:0009986 9.35 ICAM1 LTF TF TLR2 TNF
3 blood microparticle GO:0072562 9.33 CFH TF VTN
4 extracellular space GO:0005615 9.17 CFH CXCL8 ICAM1 LTF TF TNF

Biological processes related to Haemophilus Influenzae according to GeneCards Suite gene sharing:

(show all 14)
id Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.8 CXCL8 TLR2 TNF VTN
2 extracellular matrix organization GO:0030198 9.7 ICAM1 TNF VTN
3 inflammatory response GO:0006954 9.56 CLEC7A CXCL8 TLR2 TNF
4 lipopolysaccharide-mediated signaling pathway GO:0031663 9.54 TLR2 TNF
5 positive regulation of interleukin-8 production GO:0032757 9.51 TLR2 TNF
6 cellular response to lipopolysaccharide GO:0071222 9.5 CXCL8 ICAM1 TNF
7 positive regulation of NF-kappaB import into nucleus GO:0042346 9.48 TLR2 TNF
8 positive regulation of receptor-mediated endocytosis GO:0048260 9.46 TF VTN
9 embryonic digestive tract development GO:0048566 9.43 CXCL8 TNF
10 cell adhesion mediated by integrin GO:0033627 9.4 ICAM1 VTN
11 positive regulation of chemokine production GO:0032722 9.37 TLR2 TNF
12 response to molecule of bacterial origin GO:0002237 9.16 CXCL8 TLR2
13 positive regulation of leukocyte adhesion to vascular endothelial cell GO:1904996 8.96 ICAM1 TNF
14 positive regulation of NF-kappaB transcription factor activity GO:0051092 8.92 ICAM1 LTF TLR2 TNF

Molecular functions related to Haemophilus Influenzae according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 lipopolysaccharide binding GO:0001530 9.16 LTF TLR2
2 heparin binding GO:0008201 9.13 CFH LTF VTN
3 signaling pattern recognition receptor activity GO:0008329 8.62 CLEC7A TLR2

Sources for Haemophilus Influenzae

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....